Your launch strategy has never met the competition
Will your launch strategy work once it has finally left the meeting room and met the competition?
Newsletters and Deep Dive digital magazine
Will your launch strategy work once it has finally left the meeting room and met the competition?
CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.
Two Indian nationals are facing charges relating to the sale of counterfeit versions of Novo's diabetes treatment Ozempic to distributors in the US.
Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.
Sweden's Egetis has won approval in the US for the first-ever treatment for people living with the ultra-rare genetic disease MCT8 deficiency.
Editor's Picks
Newsletters and Deep Dive
digital magazine